XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Total
Series A Convertible Preferred Stock
Common Stock
Class A Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Balance, Beginning at Jan. 31, 2022 $ (395,087)   $ 15 $ 972,020 $ (4,543) $ (1,362,579)
Balance, Beginning, Shares at Jan. 31, 2022     145,081,000      
Temporary equity, Beginning, Shares at Jan. 31, 2022   500,000        
Temporary equity, Balance at Jan. 31, 2022   $ 487,880        
Stock consideration in connection with fiscal 2022 acquisition, (in shares)     559,000      
Issuance of common stock under employee equity plans, net of shares withheld for employee payroll taxes (62,336)     (62,336)    
Issuance of common stock under employee equity plans, net of shares withheld for employee payroll taxes, (in shares)     8,881,000      
Stock-based compensation related to stock awards 193,475     193,475    
Accretion and dividend on series A convertible preferred stock, net of dividends paid (17,110) $ 2,110   (17,110)    
Repurchases of common stock (267,054)   $ (1) (267,053)    
Repurchases of common stock (in shares)     (10,220,000)      
Other comprehensive loss (2,522)       (2,522)  
Net Income (Loss) 26,783         26,783
Balance, Ending at Jan. 31, 2023 (523,851)   $ 14 818,996 (7,065) (1,335,796)
Temporary equity, Ending, Shares at Jan. 31, 2023   500,000        
Temporary equity, Balance at Jan. 31, 2023   $ 489,990        
Balance, Ending, Shares at Jan. 31, 2023     144,301,000      
Issuance of common stock upon stock option exercises $ (47,097)     (47,097)    
Issuance of common stock upon stock option exercises (in shares) 89,520   6,606,000      
Stock-based compensation related to stock awards $ 207,711     207,711    
Accretion and dividend on series A convertible preferred stock, net of dividends paid (17,105) $ 2,105   (17,105)    
Repurchases of common stock (177,131)     (177,131)    
Repurchases of common stock (in shares)     (6,554,000)      
Other comprehensive loss (2,621)       (2,621)  
Net Income (Loss) 129,032         129,032
Balance, Ending at Jan. 31, 2024 $ (431,062)   $ 14 785,374 (9,686) (1,206,764)
Temporary equity, Ending, Shares at Jan. 31, 2024 500,000 500,000        
Temporary equity, Balance at Jan. 31, 2024 $ 492,095 $ 492,095        
Balance, Ending, Shares at Jan. 31, 2024     144,353,000      
Issuance of common stock under employee equity plans, net of shares withheld for employee payroll taxes $ (34,295)   $ 1 (34,296)    
Issuance of common stock under employee equity plans, net of shares withheld for employee payroll taxes, (in shares)     7,340,000      
Issuance of common stock upon stock option exercises (in shares) 1,271,158          
Stock-based compensation related to stock awards $ 219,618     219,618    
Accretion and dividend on series A convertible preferred stock, net of dividends paid (17,143) $ 2,143   (17,143)    
Repurchases of common stock (211,692)   $ (1) (211,691)    
Repurchases of common stock (in shares)     (7,580,000)      
Induced conversion of convertible notes (42,601)     (42,601)    
Purchase of capped calls related to convertible notes (52,486)     (52,486)    
Settlement of capped calls related to convertible notes 30,313     30,313    
Other comprehensive loss (2,235)       (2,235)  
Net Income (Loss) 244,621         244,621
Balance, Ending at Jan. 31, 2025 $ (296,962)   $ 14 $ 677,088 $ (11,921) $ (962,143)
Temporary equity, Ending, Shares at Jan. 31, 2025 500,000 500,000        
Temporary equity, Balance at Jan. 31, 2025 $ 494,238 $ 494,238        
Balance, Ending, Shares at Jan. 31, 2025     144,113,000